LABCORP ENDPOINT CLINICAL INC. – Trademark Portfolio
Entity Type: 03
LABCORP ENDPOINT CLINICAL INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 2 are pending. Notable registered marks include IRT, EDRS, NUDGE, PULSE, and ELOSITY. The owner is based in BURLINGTON, NC.
531 SOUTH SPRING STREET
BURLINGTON, NC 27215
Showing of trademarks Trademarks
Trademark Classifications
LABCORP ENDPOINT CLINICAL INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does LABCORP ENDPOINT CLINICAL INC. have?
LABCORP ENDPOINT CLINICAL INC. has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 2 pending.
What trademark classes does LABCORP ENDPOINT CLINICAL INC. file in?
LABCORP ENDPOINT CLINICAL INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are LABCORP ENDPOINT CLINICAL INC.'s most well-known trademarks?
LABCORP ENDPOINT CLINICAL INC.'s registered trademark portfolio includes well-known marks such as IRT, EDRS, NUDGE, PULSE, and ELOSITY. These are among 6 currently registered trademarks in the portfolio.
What is LABCORP ENDPOINT CLINICAL INC.'s trademark registration success rate?
LABCORP ENDPOINT CLINICAL INC. has a 100% trademark registration rate, with 6 out of 6 resolved applications resulting in successful registration. Currently, 2 applications are pending review.